News release: ASAP effective in vitro against TB.
Dan
ASAP Results Against Number One Human Killer
ALPINE, UT, Jun 19, 2002 /PRNewswire-FirstCall via COMTEX/ -- Clifton Mining Company (OTC: CFTN) is pleased to announce that American Biotech Labs, a company in which Clifton owns approximately 30% has finished its first set of tests using its ASAP Solution(R) against Tuberculosis, which is the number one killing infectious disease world wide. In the tests, which were conducted by an independent, EPA-approved lab, the ASAP Solution(R) achieved a greater than 97% kill rate in 45 minutes at the 10 ppm level.
In the tuberculocidal test work, the ASAP Solution(R) was tested against a challenge of approximately 47,000,000 bacterium per milliliter and achieved a kill rate, respectively, of 97.2 and 97.3% in 45 minutes on two tests.
Said Mr. Moeller, "These tests are the first step in a treatment that may have world-wide significance. Within just a few years, we may be able to save the lives of a significant number of infected children who are dying from this horrible disease. We have proven that the ASAP Solution(R) can, in fact, kill the Tuberculosis bacterium which causes a disease that kills approximately three million people a year world wide. Because the ASAP Solution has been proven non-toxic and because the TB bacterium attacks the lungs directly, our scientific staff has theorized that direct application of the product to the lungs, by use of a nebulizer, may help solve the problem. This theory, of course, will still have to be tested. We have already received very positive anecdotal data from individuals using the supplement in nebulizers for upper respiratory tract infections. So, there is a limited amount of evidence suggesting that the theory will work." The next series of tests is currently in the planning stages.
Clifton trades on the U.S. OTC: (CFTN).
Note: Any statements released by Clifton Mining Company that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company's business prospects and performance. These include economic, competitive, governmental, technological and other factors discussed in the company's business plan and due-diligence information.
SOURCE Clifton Mining Company
CONTACT: Keith W. Moeller V.P. at Clifton Mining Company 801-756-1414
ext. 41, or see our websites at www.cliftonmining.com or
American Biotech Labs' web site at www.asapsolution.com
(CFB. CFTN)
prnewswire.com
Copyright (C) 2002 PR Newswire. All rights reserved.
-0-
KEYWORD: Utah
INDUSTRY KEYWORD: MNG
News is provided by Financial Insight Systems, Inc. |
